Peroxisome proliferator–activated receptor-δ attenuates colon carcinogenesis

被引：0

作者：

Fred S Harman

Christopher J Nicol

Holly E Marin

Jerrold M Ward

Frank J Gonzalez

Jeffrey M Peters

机构：

[1] The Pennsylvania State University,Department of Veterinary Science and The Center for Molecular Toxicology and Carcinogenesis

[2] University Park,undefined

[3] Graduate Program in Biochemistry,undefined

[4] Microbiology,undefined

[5] and Molecular Biology,undefined

[6] The Pennsylvania State University,undefined

[7] University Park,undefined

[8] Laboratory of Metabolism,undefined

[9] National Cancer Institute,undefined

[10] Veterinary and Tumor Pathology Section,undefined

[11] Office of Laboratory Animal Resources,undefined

[12] National Cancer Institute,undefined

来源：

Nature Medicine | 2004年 / 10卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Peroxisome proliferator–activated receptor-δ (PPAR-δ; also known as PPAR-β) is expressed at high levels in colon tumors, but its contribution to colon cancer is unclear. We examined the role of PPAR-δ in colon carcinogenesis using PPAR-δ-deficient (Ppard−/− ) mice. In both the Min mutant and chemically induced mouse models, colon polyp formation was significantly greater in mice nullizygous for PPAR-δ. In contrast to previous reports suggesting that activation of PPAR-δ potentiates colon polyp formation, here we show that PPAR-δ attenuates colon carcinogenesis.

引用

页码：481 / 483

页数：2

共 50 条

[41] Role of Peroxisome Proliferator-Activated Receptor-γ in Atherosclerosis - An Update
Wang, Nanping
Yin, Ruiying
Liu, Yan
Mao, Guangmei
Xi, Fang
CIRCULATION JOURNAL, 2011, 75 (03) : 528 - 535
[42] Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis
Yang, Liu
Chan, Che-Chang
Kwon, Oh-Sang
Liu, Songling
McGhee, Jason
Stimpson, Stephen A.
Chen, Lihong Z.
Harrington, W. Wallace
Symonds, William T.
Rockey, Don C.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 291 (05): : G902 - G911
[43] The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
Li, Jingjing
Guo, Chuanyong
Wu, Jianye
DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2619 - 2628
[44] Lipid metabolism:: peroxisome proliferator-activated receptor-α and atherosclerosis
van Greevenbroek, MMJ
van der Kallen, CJH
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (02) : 223 - 225
[45] Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis
Ioannis A. Voutsadakis
Journal of Cancer Research and Clinical Oncology, 2007, 133 : 917 - 928
[46] Peroxisome proliferator-activated receptor-γ in macrophage lipid homeostasis
Lee, CH
Evans, RM
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (08): : 331 - 335
[47] Role of peroxisome proliferator-activated receptor-γ in hematologic malignancies
Konopleva, M
Andreeff, M
CURRENT OPINION IN HEMATOLOGY, 2002, 9 (04) : 294 - 302
[48] Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation
Toral, Marta
Romero, Miguel
Perez-Vizcaino, Francisco
Duarte, Juan
Jimenez, Rosario
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 312 (02): : H189 - H200
[49] Is peroxisome proliferator-activated receptor-γ a new "Pal" of renin?
Weatherford, Eric T.
Itani, Hana
Keen, Henry L.
Sigmund, Curt D.
HYPERTENSION, 2007, 50 (05) : 844 - 846
[50] Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis
Voutsadakis, Ioannis A.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (12) : 917 - 928

← 1 2 3 4 5 →